Jorkasky Diane
Jorkasky Diane, DIR, reported a transaction classified as grant at Altimmune, Inc. involving 48800.000000 shares for an estimated $0.00. Reported holdings after the transaction were 48800.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 01, 2026
- Filing date
- May 01, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ALT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001527204-26-000002 Stock Options (option to buy)
- Transaction date
- May 01, 2026 Filed May 01, 2026, 08:18 PM · 0d delay
- Shares
- 48,800 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 48,800 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The options were granted pursuant to the Company's non-employee director compensation policy.
- F2
The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service…
0 other transactions
0 recent txs